Prime Capital Investment Advisors, LLC Edwards Lifesciences Corp Transaction History

Prime Capital Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$84.3 - $94.31 $144,996 - $162,213	-1,720 Reduced 30.81%	3,862 $356,000
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $16,611 - $21,883	229 Added 4.28%	5,582 $533,000
Q4 2023 Jan 24, 2024	BUY	$61.71 - $77.76 $82,136 - $103,498	1,331 Added 33.09%	5,353 $408,000
Q3 2023 Nov 09, 2023	BUY	$69.28 - $93.38 $5,819 - $7,843	84 Added 2.13%	4,022 $278,000
Q2 2023 Aug 08, 2023	BUY	$81.41 - $94.33 $320,592 - $371,471	3,938 New	3,938 $371,000
Q4 2022 Feb 08, 2023	BUY	$68.3 - $87.44 $230,922 - $295,634	3,381 New	3,381 $252,000
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $32,719 - $40,142	-705 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $27,465 - $34,876	601 Added 577.88%	705 $123,000
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $4,414 - $5,335	104 New	104 $15,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.